AstraZeneca's latest COVID-19 vaccine setback

Advertisement
AstraZeneca's latest COVID-19 vaccine setback
A box containing vials of the AstraZeneca Covid-19 vaccine is pictured at the Foch hospital in Suresnes, on February 6, 2021, on the start of a vaccination campaign for health workers with the AstraZeneca/Oxford vaccine. - The top French medical authority Haute autorité de Santé has approved the vaccine for use in France, but only for people under 65, echoing decisions made in Sweden, Germany, Belgium and Switzerland over concerns about a lack of data on the effectiveness of the vaccine for over 65s.ALAIN JOCARD/AFP via Getty Images

Hello,

Advertisement

Welcome to Insider Healthcare. I'm Blake Dodge, and I cover Big Tech for the healthcare team at Insider. Here's today's news:

If you're new to this newsletter, sign up here. Tips and opinions about Google-Amazon-Microsoft-Apple in healthcare? Email me at bdodge@insider.com or tweet @dodgeblake.


AstraZeneca may have used outdated data in its US vaccine trial results, giving an 'incomplete view' of how well the shot worked, officials said

Catch up on the latest here>>


Advertisement

Early tests are planned for a COVID-19 vaccine that can be taken as a pill, with no need for injections

Read the full story>>


For 11 days in a row, more than 1 million people have flown from US airports, despite the CDC urging people not to travel

Read the full story>>


More stories we're reading today:


- Blake

Advertisement
{{}}